United States — Cost of Sales
Edwards Lifesciences United States — Cost of Sales increased by 23.1% to $172.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.8%, from $146.00M to $172.00M. Over 3 years (FY 2022 to FY 2025), United States — Cost of Sales shows an upward trend with a 14.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase relative to sales suggests margin compression or rising production costs, while a decrease relative to sales indicates improved manufacturing efficiency.
Detailed definition
This metric captures the direct costs associated with manufacturing and delivering medical devices sold within the Unite...
Peer comparison
Comparable to 'Cost of Goods Sold' (COGS) reported by other medical technology firms, adjusted for regional manufacturing footprints.
ew_segment_united_states_cost_of_salesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $104.73M | $104.73M | $104.73M | $104.73M | $126.30M | $126.30M | $126.30M | $126.30M | $139.70M | $146.40M | $126.60M | $133.90M | $146.00M | $167.50M | $167.10M | $139.70M | $172.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +20.6% | +0.0% | +0.0% | +0.0% | +10.6% | +4.8% | -13.5% | +5.8% | +9.0% | +14.7% | -0.2% | -16.4% | +23.1% |
| YoY Change | — | — | — | — | +20.6% | +20.6% | +20.6% | +20.6% | +10.6% | +15.9% | +0.2% | +6.0% | +4.5% | +14.4% | +32.0% | +4.3% | +17.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's united states — cost of sales?
- Edwards Lifesciences (EW) reported united states — cost of sales of $172.00M in Q1 2026.
- How has Edwards Lifesciences's united states — cost of sales changed year-over-year?
- Edwards Lifesciences's united states — cost of sales increased by 17.8% year-over-year, from $146.00M to $172.00M.
- What is the long-term trend for Edwards Lifesciences's united states — cost of sales?
- Over 3 years (2022 to 2025), Edwards Lifesciences's united states — cost of sales has grown at a 14.0% compound annual growth rate (CAGR), from $418.90M to $620.30M.
- What does united states — cost of sales mean?
- The direct costs incurred to produce and deliver products sold in the United States.